Ignite Creation Date:
2025-12-25 @ 4:07 AM
Ignite Modification Date:
2026-03-03 @ 6:15 AM
Study NCT ID:
NCT02185820
Status:
COMPLETED
Last Update Posted:
2023-07-03
First Post:
2014-07-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I/II Study of Carfilzomib, Pomalidomide and Dexamethasone in Relapsed And/Or Refractory Multiple Myeloma Patients (CPD)
Sponsor:
European Myeloma Network B.V.
Organization: